Two Sigma Investments, LP Galera Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.5 - $3.42 $243,197 - $332,694	97,279 Added 446.42%	119,070 $371,000
Q1 2023 May 15, 2023	BUY	$1.48 - $2.68 $32,250 - $58,399	21,791 New	21,791 $55,000
Q3 2022 Nov 14, 2022	SELL	$1.15 - $2.1 $24,938 - $45,540	-21,686 Reduced 37.18%	36,639 $64,000
Q2 2022 Aug 15, 2022	SELL	$1.24 - $2.39 $125,702 - $242,281	-101,373 Reduced 63.48%	58,325 $76,000
Q1 2022 May 16, 2022	BUY	$2.01 - $4.19 $320,992 - $669,134	159,698 New	159,698 $380,000
Q2 2021 Aug 16, 2021	SELL	$6.08 - $10.44 $114,875 - $197,253	-18,894 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.35 - $12.39 $33,533 - $49,758	4,016 Added 26.99%	18,894 $167,000
Q4 2020 Feb 16, 2021	BUY	$8.02 - $12.81 $119,321 - $190,587	14,878 New	14,878 $152,000

961K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $2.15M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.